Despite the high sensitivity and specificity of CHIT1, its use has never been introduced in routine analysis during sarcoidosis management; however, it could be included as a simple tool for FUO work-up to address granulomatous diseases as we use autoantibodies as tools to address autoimmune diseases. This evidence concerns the gene CHIT1 and autoimmune disease.